Ignite Creation Date:
2024-07-17 @ 11:22 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06494293
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-10
First Post:
2024-07-02
Brief Title:
How Many Patients Suffering Major Trauma Would be Eligible for a Pre-hospital Transfusion
Sponsor:
Hôpital NOVO
Organization:
Hôpital NOVO
Study Overview
Official Title:
How Many Patients Suffering Major Trauma Would be Eligible for a Pre-hospital Transfusion A Multicentre Retrospective Study
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TRAP
Brief Summary:
The aim of the study is to measure the number of patients being cared for by a medical team for major trauma who could benefit from a transfusion labile blood products and thus provide a scientific argument in favour of supplying labile blood products to pre-hospital
Detailed Description:
In France pre-hospital resuscitation of major trauma patients does not use labile blood products except in exceptional circumstances The physician staffed Mobile Intensive Care Unit MICU are not equipped with this type of product The first cause of death compatible with survival in the event of pre-hospital treatment identified in major trauma in war medicine is exsanguination Mortality in haemorrhagic shock occurs rapidly and appears to be significantly reduced if transfusions are performed early Early transfusion has proved its worth in the military context leading the armed forces health service to recommend transfusion as a first-line treatment as quickly as possible from the moment the patient is taken into care on the battlefield More recently in the North American civilian pre-hospital setting the PAMPer study included 501 patients 230 of whom were transfused with fresh frozen plasma FFP - 2 units The authors reported a significant reduction in mortality at D30 in the FFP group 232 vs 33 p003 It therefore seems that transfusion as early as possible is associated with a reduction in mortality in the context of major trauma
The aim of the study is to measure the number of patients being cared for by a medical team for major trauma who could benefit from a transfusion labile blood products and thus provide a scientific argument in favour of supplying labile blood products to pre-hospital
The aim of the study is to measure the number of patients being cared for by a medical team for major trauma who could benefit from a transfusion labile blood products and thus provide a scientific argument in favour of supplying labile blood products to pre-hospital
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None